This website has been developed by Besins Healthcare (UK) Ltd.

This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Testogel® (testosterone) within the UK.

Please confirm that:

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

Resources

Resources

Several resources have been created to help identify patients at risk for, or suffering from, testosterone deficiency (TD).

The Androgen Deficiency in Ageing Males (ADAM) questionnaire and the Ageing Males’ Symptoms (AMS) scale are two clinically validated tools to help quickly evaluate the possible presence, and severity, of TD.

Additionally, the waist-to-height calculator can also be used to roughly predict your patient’s likelihood of TD.1,2

HCP resources

AMS scale AMS scale
ADAM questionnaire ADAM questionnaire
Waist-to-height calculator Waist-to-height calculator
New Education Hub New Education Hub
BSSM guidelines BSSM guidelines
BMI calculator BMI calculator

Videos

How to apply Testogel® 16.2 mg/g gel

How to prepare your pump dispenser containing Testogel® 16.2 mg/g gel for the first time and for daily application. Application instructions apply for both Testogel® 16.2 mg/g gel and Testogel® 40.5 mg, transdermal gel in sachet.

1:25
Helpful

Duration of testosterone therapy

Professor Abraham Morgentaler of the Harvard Medical School in Boston discusses the duration of testosterone therapy.

1:20
Helpful

Tests needed prior to treatment

Watch Professor Geoff Hackett from the University of Bedfordshire discuss the tests needed before putting a man on testosterone.

1:25
Helpful

When is treatment recommended?

Watch Professor Geoff Hackett from the University of Bedfordshire discuss the recommended level of testosterone at which to treat testosterone deficiency in men.

2:02
Helpful

Common symptoms

Watch Professor Abraham Morgentaler of the Harvard Medical School in Boston discuss common symptoms of testosterone deficiency.

1:45
Helpful

Who testosterone therapy is suitable for

Watch Professor Abraham Morgentaler of the Harvard Medical School in Boston discuss testosterone therapy and who it is suitable for.

1:20
Helpful

Download the Testogel® 16.2 mg/g gel Patient Package Leaflet.

Download the Testogel® 40.5 mg, transdermal gel in sachet Patient Package Leaflet.

Want to talk Testogel®?

    Please fill in the form below to join our consent list where you’ll receive the latest healthcare, medical and promotional information around BHUK products via email and/or SMS. This includes medical and scientific information and events, invitations to Besins-organised promotional speaker meetings, promotional information and material and links to available online resources.

    Therapy areas of interest:
    *Required field

    By filling in this form and clicking the “Submit” button, I confirm I am a healthcare professional in the UK or Ireland and I consent to receiving healthcare, medical and scientific related information, by email or other electronic means. This may include promotional information on products promoted by Besins Healthcare. If you’d like more information, you can read our privacy notice here.

    Adverse events should not be submitted via this form.

    Support patient self-management with the T Track app

    Encourage your patients to review their symptoms using the Ageing Males’ Symptom (AMS) scale in the T Track app and monitor their progress over time.

    Find out about the T Track app

    T Track app available for both iOS and Android phones.

    Download on the Apple App Store Get it on Google Play
    Support patient self-management with the T Track app

    References

    1. Allan C, Peverill R, Strauss B, et al. Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency. Asian J Androl. 2011;13(3): 424–431.
    2. Hackett G, Kirby M, Edwards D, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. J Sex Med. 2017;14(12):1504–1523.

    BHUK/2023/641. October 2023.

    Adverse event reporting

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: pharmacovigilance@besins-healthcare.com

    Where next...